UbiVac, Inc.
PrivateLast Round
Seed Round
Aug 27, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
UbiVac, Inc. is a biotechnology company that develops therapeutic vaccines and immunotherapies to combat cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
UbiVac, Inc. Comparables
Compare UbiVac, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PDC*line Pharma | 84% | |
| Corner Therapeutics | 82% | |
| EV Therapeutics | 81% | |
UbiVac, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 27, 2026 | ||||
| VC Round | Apr 8, 2022 | ||||
| Corporate Funding | Sep 29, 2015 |
UbiVac, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
$80K seed round completed.
- May 12, 2026
Monthly visitors grew 450% MoM, reaching 1.7K.
UbiVac, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about UbiVac, Inc.'s valuation, stock price, and market status.